Gapping up
In reaction to earnings/guidance:
- VRM +33.3% (also CEO Paul Hennessy steps down; Tom Shortt appointed as CEO), SWAV +14.6%, CLOV +14.5% (also files for $300 mln mixed securities shelf offering), ITCI +11.6%, MESA +8.3%, FGEN +8.3%, AZEK +7%, UNVR +6.7%, BLDR +6.6%, XPO +6.3%, BLI +6.3%, LPSN +5.9%, CRNC +5.8%, AMC +5.6%, IGT +5.6%, HRTX +5.3%, FROG +5.3%, RNG +5% (also names new CFO), EVRI +5%, ROVR +4.8%, DFH +4.8%, FSK +4.7% (also increases distribution payout), IIVI +4.6%, BLUE +4.5%, ASX +4.4%, LI +4.3%, HI +4%, OPRT +3.8%, SONY +3.7%, SDC +3.3%, HL +3.1%, MGY +3%, HIMS +3%, MCHP +2.9% (also increases dividend), ALGM +2.8% (also CEO to retire), TREX +2.8%, AMWL +2.6%, IFF +2.6%, H +2.6%, MBUU +2.5%, MRC +2.3%, ARMK +2.3% (plans to separate uniform services into publicly traded company), NVEI +2.3%, CRSP +2%, TSM +2%, NXST +2%, PLNT +1.8%, BLNK +1.4%, SWX +1.4%, ZNGA +1.2%, SU +1%
Other news:
- BHVN +70.3% (Biohaven Pharmaceutical and Pfizer (PFE) announce that the companies have entered into a definitive agreement under which Pfizer will acquire Biohaven)
- NVVE +10.2% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
- SNCR +5.9% (signs multi-year agreement with Brightspeed)
- VERV +4.9% (outlines its global development strategy for its lead gene editing candidate VERVE-101 and reported financial results for the first quarter ended March 31 2022)
- CENN +4.7% (NVVE and CENN announce alliance to offer electrification solution for commercial fleets)
- OTIS +3.7% (completes squeeze out provision to acquire remaining interest in Zardoya Otis)
- SFIX +2.6% (D. E. Shaw increases passive stake to 5%)
- CVNA +2.6% (announces the $2.2 bln acquisition of ADESA's U.S. physical auction business from KAR Global (KAR))
- ARIS +2.3% (announces water mgmt agreement with Chevron USA)
- ARMK +2.3% (plans to separate uniform services into publicly traded company)
- MULN +1.9% (announces an update on Mullen's solid-state polymer battery testing with the Battery Innovation Center in Indiana)
- MTCH +1.8% (MTCH sues GOOG over alleged unlawful billing mandates)
- BRSP +1.6% (authorizes new $100 mln share repurchase program)
- BIIB +1.5% (Biogen and Eisai complete rolling submission to the FDA for biologics license application of Lecanemab)
- FSLY +1.1% (postpones Investor Day)
Analyst comments:
- ALV +4.3% (upgraded to Buy from Neutral at UBS)
- CLNE +3.8% (upgraded to Outperform from Mkt Perform at Raymond James)
- PBH +3.6% (upgraded to Buy from Hold at Jefferies)
- GPK +2.5% (upgraded to Outperform from Neutral at Exane BNP Paribas)